This strongly suggests that treatment with P1446A leads to rapid ASK1 activation in CLL with subsequent phosphorylation of stress kinases JNK and p38 MAPK, ultimately leading to cell apoptosis. The gene discussed is MAP3K5; the disease is B-cell chronic lymphocytic leukemia.